Synthesizing evidence from multiple studies: The role of meta-analysis in pharmacoeconomics

Medical Care

Volumn 34, Issue 12 SUPPL., 1996, Pages

  Lafata, Jennifer Elston ^a   Koch, Gary G ^b   Ward, Richard E ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b IL   (United States)

Author keywords

Cost containment strategies; Meta analysis, pharmacoeconomics; Pharmacoeconomics

Indexed keywords

ARTICLE; CLASSIFICATION; COST CONTROL; HEALTH SERVICES RESEARCH; HUMAN; META ANALYSIS; METHODOLOGY; PHARMACOECONOMICS; STANDARD;

COST CONTROL; ECONOMICS, PHARMACEUTICAL; HEALTH SERVICES RESEARCH; HUMANS; META-ANALYSIS; RESEARCH DESIGN;

EID: 0030338735     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Drummond MF, Stoddart GL. Economic analysis and clinical trials. Controlled Clin Trials 1984;5:115.
2. Drummond MF, Davies LM. Economic analysis alongside clinical trials: Revisiting the methodological Issues. International J Tech Assessment in Health Care 1991;7:561.
3. Glass GV. Primary, secondary, and meta-analysis of research. Educ Res 1976;5:3.
4. Feto R. Why do we need systematic overviews of randomized trials? Stat Med 1987;6:233.
5. Chalmers TC, Buyse ME. Meta-analysis. In: Chalmers T, ed. Data Analysis for Clinical Medicine: The Quantitative Approach to Patient Care in Gastroenterology. Rome: International University Press, 1988.
6. Bulpitt CJ. Medical Statistics: Meta-analysis. Lancet 1988;2:93.
7. Hedges L, Olkin I. Statistical Methods for Meta-Analysis. New York: Academic Press, 1985.
8. Elashoff JD, Koch GG. Statistical methods in trials of anti-ulcer drugs. In: Swabb E, Szabo S, eds. Ulcer Disease: Investigation and Basis for Therapy. New York: Marcel Dekker, 1990.
9. Torrance, GN. Measurement of health state utilities for economic appraisal: A review. J Health Economics 1986;5:1.
10. Letzel H. Best-evidence synthesis: An intelligent alternative to meta-analysis: discussion. A case of "either-or"or "as well." J Clin Epidemiol 1995;48:19.
11. Rosenthal R, Rubin D. Comparing significance levels of independent studies. Psychology Bulletin 1979;86:1165.
12. Kraemer HC, Andrews G. A nonparametric technique for meta-analysis effect size calculation. Psychology Bulletin 1982;91:404.
13. Light, RJ. Accumulating evidence from independent studies: What we can win and what we can Lose. Stat Med 1987;6:221.
14. Wachter KW. Disturbed by meta-analysis? Science 1988;241:1407.
15. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177.
16. Schmid, JE, Koch GG, LaVange LM. An overview of statistical issues and methods of meta-analysis. Journal of Biopharmaceutical Statistics 1991;1:103.
17. Koch GG, Schmid JE, Begun JM, Maier WC. Meta-analysis of drug safety data. In: Sogliero-Gilbert G, ed. Drug Safety Assessment in Clinical Trials. New York: Marcel Dekker, 1993.
18. O'Brien BJ, Drummond MF, Labelle RJ, Willan A. In search of power and significance: Issues in the design and analysis of stochastic cost-effectiveness studies in health care. Med Care 1994;32:10.
19. Van Hout BA, AL MJ, Gordon GS, Rutten FF. Costs, Effects and C/E-Ratios alongside a Clinical Trial. Health Economics 1994;3:309.
20. Gardiner J, Hogan A, Holmes-Rovner M, Rovner D, Griffith L, Kupersmith J. Confidence intervals for cost-effectiveness ratios. Medical Decision Making 1995; 15:254.
21. Einarson TR, Arikian S, Sweeney S, Doyle J. A model to evaluate the cost-effectiveness of oral therapies in the management of patients with major depressive disorders. Clinical Therapies 1995;17:136.
22. Liang KL, Zeger SL. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;2:121.
23. Zeger SL, Liang KL, Albert PS. Models for longitudinal data: A generalized estimating equation approach. Biometrics 1988;55:352.
24. LaVange LM. Application of sample survey methods for modeling ratios to incidence densities. Stat Med 1994;13:343.
25. Shah, BV, Barnwell BG, Hunt PN, LaVange LM. SUDAAN User's Manual, Release 5.50. Research Triangle Park: Research Triangle Institute, 1991.
26. Bauer P. Multiple testing in clinical trials. Stat Med 1991;10:871.
27. Gansky SA, Koch GG, Wilson J. Statistical evaluation of relationship between analgesic dose and ordered ratings of pain relief over an eight hour period. Journal of Biopharmaceutical Statistics. 1994;42:233.
28. Koch GG, Gansky SA. Statistical considerations for multiplicity in confirmatory protocols. Drug Information Journal; 1996;30:523.